dihydrolenperone has been researched along with Lung Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baltz, J; Bastian, A; Johnson, BE; Miller, MJ; Parker, R; Phares, J; Phelps, R; Shoemaker, R; Stocker, J; Tsai, CM | 1 |
1 trial(s) available for dihydrolenperone and Lung Neoplasms
| Article | Year |
|---|---|
Phase I trial of dihydrolenperone in lung cancer patients: a novel compound with in vitro activity against lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Butyrophenones; Chromatography, High Pressure Liquid; Drugs, Investigational; Female; Haloperidol; Humans; Lung Neoplasms; Male; Middle Aged; Tumor Cells, Cultured | 1993 |